Skip to contentPERCEPTIVE ADVISORS LLC — XTL BIOPHARMACEUTICALS LTD insider: 358 transactions · InsiderLensPERCEPTIVE ADVISORS LLC
- 10% owner at SOLENO THERAPEUTICS INC · on record since May 26, 2023
- 10% owner at CHEMBIO DIAGNOSTICS, INC. · on record since Apr 25, 2023
- Former 10% Owner at CHEMBIO DIAGNOSTICS, INC. · on record since May 1, 2023
- 10% owner at INDEVUS PHARMACEUTICALS INC · on record since Jun 29, 2006
- Former 10% Owner at CARGO Therapeutics, Inc. · on record since Nov 14, 2023
- 10% owner at CARGO Therapeutics, Inc. · on record since Nov 9, 2023
- 10% owner at FELAFEL CORP · on record since Jun 27, 2024
- 10% owner at Orchestra BioMed Holdings, Inc. · on record since Jul 17, 2024
- Director at Adagio Medical Holdings, Inc. · on record since Aug 1, 2024
- 10% owner at Adagio Medical Holdings, Inc. · on record since Aug 1, 2024
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 27, 2021
- 10% owner at BIOENVISION INC · on record since Aug 22, 2007
- 10% owner at XTL BIOPHARMACEUTICALS LTD · on record since Dec 31, 2007
- 10% owner at MACROCHEM CORP · on record since Dec 28, 2007
- 10% owner at OPTIMER PHARMACEUTICALS INC · on record since Dec 27, 2007
- 10% owner at PENWEST PHARMACEUTICALS CO · on record since Jan 31, 2008
- Director at Immatics N.V. · on record since Mar 18, 2026
- Director at Kardigan, Inc. · on record since Jun 18, 2026
- Director at ARYA SCIENCES ACQUISITION CORP. · on record since May 24, 2021
- Managing Member at CYPRESS BIOSCIENCE INC · on record since Aug 8, 2003
- 10% owner at BIOSANTE PHARMACEUTICALS INC · on record since Aug 13, 2003
- Managing Member at BIOSANTE PHARMACEUTICALS INC · on record since Aug 13, 2003
- 10% owner at MIRAVANT MEDICAL TECHNOLOGIES · on record since Jun 8, 2004
- 10% owner at ZONAGEN INC · on record since Feb 28, 2011
- 10% owner at TRIMERIS INC · on record since Jul 29, 2011
- 10% owner at AP PHARMA INC /DE/ · on record since Jul 7, 2011
- Director at MeiraGTx Holdings plc · on record since Apr 23, 2026
- 10% owner at MeiraGTx Holdings plc · on record since Apr 23, 2026
- 10% owner at ACELRX PHARMACEUTICALS INC · on record since Dec 13, 2012
- 10% owner at Aegerion Pharmaceuticals, Inc. · on record since Dec 5, 2012
- 10% owner at ANTARES PHARMA INC · on record since Feb 12, 2004
- 10% owner at AMICUS THERAPEUTICS INC · on record since May 30, 2014
- Director at Solid Biosciences Inc. · on record since Jun 11, 2026
- 10% owner at Solid Biosciences Inc. · on record since Jun 11, 2026
- 10% owner at PAULSON CAPITAL CORP · on record since Mar 11, 2015
- 10% owner at Aldeyra Therapeutics, Inc. · on record since Oct 28, 2015
- Former Director at Nautilus Biotechnology, Inc. · on record since Jun 11, 2021
- 10% owner at Versartis, Inc. · on record since Sep 28, 2016
- No longer a 10% Owner. at AMICUS THERAPEUTICS INC · on record since Aug 26, 2016
- 10% owner at CORILLIAN CORP · on record since May 25, 2017
- 10% owner at ZOGENIX, INC. · on record since May 18, 2017
- 10% owner at Quotient Ltd · on record since Oct 26, 2017
- 10% owner at Global Blood Therapeutics, Inc. · on record since Dec 19, 2017
- 10% owner at LA JOLLA PHARMACEUTICAL CO · on record since Dec 18, 2017
- 10% owner at R&R ACQUISITION VI, INC · on record since Nov 15, 2017
- 10% owner at Biodel Inc · on record since Dec 4, 2017
- 10% owner at AGILE THERAPEUTICS INC · on record since Mar 28, 2018
- 10% owner at Motus GI Holdings, Inc. · on record since Feb 21, 2018
- 10% owner at Kadmon Holdings, LLC · on record since Jun 22, 2018
- 10% owner at Dova Pharmaceuticals, Inc. · on record since Jun 13, 2018
- Director at Crinetics Pharmaceuticals, Inc. · on record since Aug 27, 2018
- 10% owner at Crinetics Pharmaceuticals, Inc. · on record since Aug 27, 2018
- Former 10% Owner at AGILE THERAPEUTICS INC · on record since Jul 26, 2018
- Former 10% Owner at Global Blood Therapeutics, Inc. · on record since Jul 25, 2018
- 10% owner at Verrica Pharmaceuticals Inc. · on record since Aug 1, 2018
- 10% owner at Athenex, Inc. · on record since Jun 20, 2019
- 10% owner at Foamix Pharmaceuticals Ltd. · on record since Aug 6, 2019
- Former 10% owner at Kadmon Holdings, LLC · on record since Nov 18, 2019
- Director at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- 10% owner at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- 10% owner at LEAP THERAPEUTICS, INC. · on record since Jun 24, 2020
- 10% owner at VYNE Therapeutics Inc. · on record since Jun 11, 2020
- 10% owner at LeonaBio, Inc. · on record since Sep 22, 2020
- Director at Ceres, Inc. · on record since Oct 29, 2020
- Director at ARYA Sciences Acquisition Corp II · on record since Oct 22, 2020
- Director at LeonaBio, Inc. · on record since Jan 27, 2021
- 10% owner at SCYNEXIS INC · on record since Jan 26, 2021
- 10% owner at Ignyta, Inc. · on record since Mar 16, 2021
- Director at Landos Biopharma, Inc. · on record since Feb 9, 2021
- 10% owner at Landos Biopharma, Inc. · on record since Feb 9, 2021
- Director at CATABASIS PHARMACEUTICALS INC · on record since Feb 3, 2021
- 10% owner at CATABASIS PHARMACEUTICALS INC · on record since Feb 3, 2021
- Director at LianBio · on record since Oct 29, 2021
- 10% owner at LianBio · on record since Oct 29, 2021
- 10% owner at ISCO INTERNATIONAL INC · on record since Oct 14, 2021
- Director at Nautilus Biotechnology, Inc. · on record since Dec 10, 2021
- 10% owner at Nautilus Biotechnology, Inc. · on record since Jun 17, 2022
- 10% owner at Acrivon Therapeutics, Inc. · on record since Nov 18, 2022
Insider trading activity of PERCEPTIVE ADVISORS LLC
- Transactions on record
- 358
- since Jan 5, 2007
- Open-market buys
- 210
- $448.8M
- Open-market sells
- 49
- $121.7M
- Companies traded
- 42
- last filing Jun 18, 2026
Figures computed from official regulatory filings — methodology.
Companies where PERCEPTIVE ADVISORS LLC has traded
- Immatics N.V.1 tx · Jun 18, 2026
- MeiraGTx Holdings plc13 tx · $11.4M · Jun 15, 2026
- Solid Biosciences Inc.6 tx · $29.7M · Jun 11, 2026
- LeonaBio, Inc.9 tx · $82.5M · Dec 23, 2025
- Lyra Therapeutics, Inc.21 tx · $33.5M · Nov 13, 2025
- Acrivon Therapeutics, Inc.5 tx · $3.8M · May 1, 2025
- Adagio Medical Holdings, Inc.1 tx · Feb 14, 2025
- Nautilus Biotechnology, Inc.2 tx · Jun 17, 2024
- Ceres, Inc.4 tx · $4.8M · Feb 21, 2024
Track record of PERCEPTIVE ADVISORS LLC
Statistical track record
Free- Open-market buys
- 221
- Last buy
- Dec 26, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of PERCEPTIVE ADVISORS LLC
Co-insiders of PERCEPTIVE ADVISORS LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
11 tx · $25.2M · Dec 26, 2023
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 18, 2026 | AwardD | 48,000 | 0.00 USD | — | SEC |
| Jun 15, 2026 | AwardD | 60,000 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | AwardD | 77,500 | 0.00 USD | $0 | SEC |
| Apr 23, 2026 | AwardD | 300,000 | — | — | SEC |
| Apr 23, 2026 | OtherD | -400,000 | — | — | SEC |
| Apr 23, 2026 | AwardD | 400,000 | — | — | SEC |
| Apr 23, 2026 | AwardD | 400,000 | — | — | SEC |
| Apr 23, 2026 | Award | 555,555 | 9.00 USD | $5M | SEC |
| Apr 23, 2026 | OtherD | -300,000 | — | — | SEC |
| Apr 23, 2026 | AwardD | 300,000 | — | — | SEC |
| Dec 23, 2025 | AwardD | 1,372,935 | 6.35 USD | $8.7M | SEC |
| Dec 23, 2025 | AwardD | 1,279,526 | 6.35 USD | $8.1M | SEC |
| Dec 23, 2025 | AwardD | 5,502,402 | — | — | SEC |
| Dec 23, 2025 | AwardD | 3,838,583 | 6.35 USD | $24.4M | SEC |
| Dec 23, 2025 | AwardD | 1,181,101 | 6.35 USD | $7.5M | SEC |
| Dec 23, 2025 | AwardD | 457,645 | 6.35 USD | $2.9M | SEC |
| Dec 23, 2025 | Award | 989,270 | 6.35 USD | $6.3M | SEC |
| Dec 23, 2025 | AwardD | 3,543,307 | 6.35 USD | $22.5M | SEC |
| Dec 23, 2025 | Award | 329,756 | 6.35 USD | $2.1M | SEC |
| Nov 13, 2025 | Sell | -537 | 4.31 USD | $2.3K | SEC |
| Nov 13, 2025 | Sell | -883 | 4.06 USD | $3.6K | SEC |
| Nov 13, 2025 | Sell | -28,597 | 3.90 USD | $111.5K | SEC |
| Nov 13, 2025 | Sell | -3,213 | 3.90 USD | $12.5K | SEC |
| Nov 13, 2025 | Sell | -7,862 | 4.06 USD | $31.9K | SEC |
| Nov 13, 2025 | Sell | -4,783 | 4.31 USD | $20.6K | SEC |